BNTX
BioNTech SE
Company Overview
| Mkt Cap | $25.20B | Price | $103.91 |
| Volume | 557.86K | Change | -0.73% |
| P/E Ratio | -37.9 | Open | $104.03 |
| Revenue | $2.8B | Prev Close | $104.67 |
| Net Income | $-665.3M | 52W Range | $81.20 - $129.27 |
| Div Yield | N/A | Target | $135.84 |
| Overall | 54 | Value | -- |
| Quality | -- | Technical | 54 |
No chart data available
Stock Overview
Updated DailyBioNTech SE (BNTX) is a leading Manufacturing company in the Biological Product (except Diagnostic) Manufacturing industry, currently trading at $103.91 with a market capitalization of $25.20 billion. The stock is trading in the middle of its 52-week range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows BNTX with a volume of 558K shares. The stock opened down 0.61% from yesterday's close of $104.67. Current analyst estimates project earnings of $-3.86 per share for this year, with next year targeting $-3.58.
BNTX demonstrates neutral technical outlook based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including ORTH-CA, OTIC, OTLC, OTLK.
Key investment considerations for BNTX include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 30.7%. The stock shows neutral valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 02:56 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BNTX | $103.91 | -0.7% | 557.86K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |